Board Meeting7 May 2026, 11:21 pm
Shukra Pharma Allots 17.35 Lakh Equity Shares on Warrant Conversion
AI Summary
Shukra Pharmaceuticals Ltd. has allotted 17,35,000 fully paid-up equity shares to Dakshesh Shah and Parshva Texchem India Private Limited (Promoters) upon conversion of warrants. The allotment was made for cash, with the company receiving ₹4,42,42,500. Consequent to this allotment, the paid-up equity capital increased from ₹43,78,79,440 to ₹43,96,14,440. The board also approved the audited financial results for the year ended March 31, 2026, and recommended a final dividend of ₹0.01 per share.
Key Highlights
- Shukra Pharma allots 17,35,000 equity shares to promoters on warrant conversion.
- Company receives ₹4,42,42,500 from the warrant conversion.
- Paid-up equity capital increases to ₹43,96,14,440 post-allotment.
- Board approves audited financial results for the year ended March 31, 2026.
- Final dividend of ₹0.01 per share recommended for FY26.
Price Impact
More from SHUKRAPHAR